drugset / Trial / NCT02080767
Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure
Summary
The purpose of this clinical protocol is to treat individuals with Tecovirimat after exposure to orthopox viruses.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tecovirimat | Small molecule | 600 mg | Oral |